The non-university research institutes belonging to the Baden-Württemberg Innovation Alliance are evaluated at regular intervals on behalf of the State Ministry of Economics. The report on the current

The aim of the research project is to develop wound dressings that contain probiotic bacteria living in a sterile collagen matrix. The probiotic bacteria are encapsulated using the PEM process and inc

In a recent IHK statement on the PFAS debate, Dr. Dagmar Martin from the NMI emphasizes the challenges that a comprehensive PFAS ban would pose for research and industry. In a recent Statement from th

The immune response to implanted medical devices can impact their performance and longevity in the body. Instead of designing implants to produce the desired immune responses, this might more easily b

This year, the NMI will be represented at the BW Congress with a joint stand of the Baden-Württemberg Innovation Alliance (innBW). We look forward to presenting our research and development activities

Together with five other institutes belonging to innBW, the NMI presented its services at the KongressBW in the Liederhalle in Stuttgart on October 22 and 23. At KongressBW, six institutes belonging t

Organoid electrophysiology and mesh microelectrode arrays Dr. Peter D. Jones Group Leader Biomedical Micro and Nano Engineering +49 7121 51530-800 E-Mail anzeigen Advanced solutions for organoid, sphe

The Hepatitis B surface antigen (HBsAg) as the only lipid-associated envelope protein of the Hepatitis B virus (HBV) acts as cellular attachment and entry mediator of HBV making it the main target of

The pregnane X receptor (PXR) is an important regulator of hepatic metabolism, yet mechanistic insights into the effects of pharmacological inhibition using PXR inverse agonists or antagonists on crit

We identified potential modifiers of regorafenib response, including BCL2, BCL2L1, ITGB3, FOXC1, SERAC1, ARAF, and PLCE1. The combination of regorafenib with Bcl-2/Bcl-xL inhibition was superior to bo